Home › Heart Failure › Washington › Spokane
Heart Failure clinical trials in Spokane, WA
3 studies for Heart Failure are looking for participants at sites in and around Spokane (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
RecruitingPhase 3
- Providence Advanced Heart Disease and Transplant, Spokane
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RecruitingPhase 3
- Spokane, WA Investigative Site 10123, Spokane
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
RecruitingPhase 3
- Providence Sacred Heart Medical Center, Spokane
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY51 studies
- Boston, MA46 studies
- Dallas, TX42 studies
- Houston, TX35 studies
- Cleveland, OH31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- Chicago, IL28 studies
- Durham, NC25 studies
- Kansas City, MO25 studies
- St. Louis, MO24 studies
- Indianapolis, IN24 studies
Other studies in Spokane
- Non-Small Cell Lung Cancer10 studies
- Breast Cancer8 studies
- Ovarian Cancer8 studies
- Colorectal Cancer8 studies
- Parkinson's Disease8 studies
- Prostate Cancer7 studies
- Cancer (all types)6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Chronic Lymphocytic Leukemia6 studies
- Melanoma5 studies
- Triple-Negative Breast Cancer5 studies
- Geographic Atrophy5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.